An engineered, orthogonal ligand receptor pair has been exploited as a method to covalently label fusion proteins with small molecule probes in live cells.
No takes yet. Share an insight, caveat, or question.
Krusemark et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: